277 related articles for article (PubMed ID: 33933885)
21. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
22. In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection.
Vivek-Ananth RP; Rana A; Rajan N; Biswal HS; Samal A
Molecules; 2020 Aug; 25(17):. PubMed ID: 32842606
[TBL] [Abstract][Full Text] [Related]
23. The key features of SARS-CoV-2 leader and NSP1 required for viral escape of NSP1-mediated repression.
Bujanic L; Shevchuk O; von Kügelgen N; Kalinina A; Ludwik K; Koppstein D; Zerna N; Sickmann A; Chekulaeva M
RNA; 2022 May; 28(5):766-779. PubMed ID: 35232816
[TBL] [Abstract][Full Text] [Related]
24. The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients.
Shen M; Ding P; Luan G; Du T; Deng S
Front Cell Infect Microbiol; 2023; 13():1141274. PubMed ID: 36960047
[TBL] [Abstract][Full Text] [Related]
25. Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA.
Yuan S; Peng L; Park JJ; Hu Y; Devarkar SC; Dong MB; Shen Q; Wu S; Chen S; Lomakin IB; Xiong Y
Mol Cell; 2020 Dec; 80(6):1055-1066.e6. PubMed ID: 33188728
[TBL] [Abstract][Full Text] [Related]
26. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.
Balkrishna A; Mittal R; Arya V
Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643
[TBL] [Abstract][Full Text] [Related]
27. Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host.
Agrawal S; Pathak E; Mishra R; Mishra V; Parveen A; Mishra SK; Byadgi PS; Dubey SK; Chaudhary AK; Singh V; Chaurasia RN; Atri N
Comput Biol Med; 2022 Oct; 149():106049. PubMed ID: 36103744
[TBL] [Abstract][Full Text] [Related]
28. All Domains of SARS-CoV-2 nsp1 Determine Translational Shutoff and Cytotoxicity of the Protein.
Frolov I; Agback T; Palchevska O; Dominguez F; Lomzov A; Agback P; Frolova EI
J Virol; 2023 Mar; 97(3):e0186522. PubMed ID: 36847528
[TBL] [Abstract][Full Text] [Related]
29. Discovery of potent inhibitors for SARS-CoV-2's main protease by ligand-based/structure-based virtual screening, MD simulations, and binding energy calculations.
Abu-Saleh AAA; Awad IE; Yadav A; Poirier RA
Phys Chem Chem Phys; 2020 Oct; 22(40):23099-23106. PubMed ID: 33025993
[TBL] [Abstract][Full Text] [Related]
30. Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2.
Maurya SK; Maurya AK; Mishra N; Siddique HR
J Recept Signal Transduct Res; 2020 Dec; 40(6):605-612. PubMed ID: 32476594
[TBL] [Abstract][Full Text] [Related]
31. Structural Basis and Function of the N Terminus of SARS-CoV-2 Nonstructural Protein 1.
Zhao K; Ke Z; Hu H; Liu Y; Li A; Hua R; Guo F; Xiao J; Zhang Y; Duan L; Yan XF; Gao YG; Liu B; Xia Y; Li Y
Microbiol Spectr; 2021 Sep; 9(1):e0016921. PubMed ID: 34132580
[TBL] [Abstract][Full Text] [Related]
32. Universal features of Nsp1-mediated translational shutdown by coronaviruses.
Schubert K; Karousis ED; Ban I; Lapointe CP; Leibundgut M; Bäumlin E; Kummerant E; Scaiola A; Schönhut T; Ziegelmüller J; Puglisi JD; Mühlemann O; Ban N
Mol Cell; 2023 Oct; 83(19):3546-3557.e8. PubMed ID: 37802027
[TBL] [Abstract][Full Text] [Related]
33. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
34.
Sharma A; Goyal S; Yadav AK; Kumar P; Gupta L
J Biomol Struct Dyn; 2022 Jan; 40(1):86-100. PubMed ID: 32896226
[TBL] [Abstract][Full Text] [Related]
35. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
[TBL] [Abstract][Full Text] [Related]
36. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19.
Vardhan S; Sahoo SK
Comput Biol Med; 2020 Sep; 124():103936. PubMed ID: 32738628
[TBL] [Abstract][Full Text] [Related]
37. Revealing druggable cryptic pockets in the Nsp1 of SARS-CoV-2 and other β-coronaviruses by simulations and crystallography.
Borsatto A; Akkad O; Galdadas I; Ma S; Damfo S; Haider S; Kozielski F; Estarellas C; Gervasio FL
Elife; 2022 Nov; 11():. PubMed ID: 36412088
[TBL] [Abstract][Full Text] [Related]
38. Molecular Basis of SARS-CoV-2 Nsp1-Induced Immune Translational Shutdown as Revealed by All-Atom Simulations.
Borišek J; Spinello A; Magistrato A
J Phys Chem Lett; 2021 Dec; 12(48):11745-11750. PubMed ID: 34851631
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 NSP1 induces mRNA cleavages on the ribosome.
Tardivat Y; Sosnowski P; Tidu A; Westhof E; Eriani G; Martin F
Nucleic Acids Res; 2023 Sep; 51(16):8677-8690. PubMed ID: 37503833
[TBL] [Abstract][Full Text] [Related]
40. Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study.
Wang J
J Chem Inf Model; 2020 Jun; 60(6):3277-3286. PubMed ID: 32315171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
